Ensuring that the right patients get the right treatments at the right time

Global Market Access

A Comprehensive Approach to HTA, Strategy and Communication

In today’s world, any new health technology that is aimed at addressing a specific disease condition must factor the payers' expectations and requirements into its research program from its earliest stages. Mapi helps support your research and development teams, as well as your market access organization, to take these factors into consideration and determine which key product and market attributes will be needed to ensure the launch of a differentiated product that will meet the Health Technology Assessment (HTA) bodies and payers' requirements. Mapi aims to provide you with global strategic HTA expertise in combination with the right analytics and evidence to reach a target price and optimize access. Our in-house team of experienced HTA and Access experts, medical writers, health economists, and systematic reviewers enable us to provide you with the complete package of HTA, strategy, and communication services to achieve global market access. This includes many senior experts who bring a wealth of experience in successful project delivery.

Mapi provides a full range of market access services:

Request a consultation with an RWS&A expert